Effects of antidepressant drugs on sexual function

References

• Baldwin D S. Depression and sexual function. J Psychopharmacol [1996] 1996; 10(suppt 1)30–34
   Google Scholar
• Kivela S-L, Pahkala K. Symptoms of depression in aged Finns. Int J Soc Psychiatry 1988; 34: 274–284
   PubMedGoogle Scholar
• Matthew R J, Weinman M L. Sexual dysfunction in depression. Arch Sexual Behaviour 1982; 11: 323–328
   PubMed Web of Science ®Google Scholar
• Schreiner-Engel P, Schiavi R C. Lifetime psychopathology in inviduals with low sexual desire. J Nervous Mental Dis 1986; 174: 646–651
   PubMed Web of Science ®Google Scholar
• Swan M, Wilson M J. Sexual and marital problems in a psychiatric outpatient population. Br J Psychiatry 1979; 135: 310–314
   PubMed Web of Science ®Google Scholar
• Kockott G, Pfeiffer W. Sexual disorders in non-acute psychiatric out-patients. Comp Psychiatry 1996; 37: 56–61
   PubMed Web of Science ®Google Scholar
• Fagan P J, Schmidt C W, Jr, Wise T N, et al. Sexual dysfunction and dual psychiatric diagnoses. Comp Psychiatry 1988; 29: 278–284
   PubMed Web of Science ®Google Scholar
• Segraves R T. Effect of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989; 46: 275–284
   PubMed Web of Science ®Google Scholar
• Wilson C A. Pharmacological targets for the control of male and female sexual behaviour. Sexual pharmacology, A Riley, M Peet, C Wilson. Oxford Medical Publications, Oxford 1993; 1–58
   Google Scholar
• Baldwin D S, Thomas S C. Depression and sexual junction. Martin Dunitz, London 1996
   Google Scholar
• Segraves R T. Treatment-emergent sexual dysfunction in affective disorder: a review and management strategies. J Clin Psychiatry (monograph) 1993; 11: 57–60
   Google Scholar
• Baldwin D S. Psychotropic drugs and sexual dysfunction. Int Rev Psychiatry 1995; 7: 261–273
   Web of Science ®Google Scholar
• Balon R, Yeragani V K, Pohl R, Ramesh C. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 54: 209–212
   PubMed Web of Science ®Google Scholar
• Baier D, Philipp M. Effects of antidepressants on sexual function. Fortschr Neurol Psychiatr 1994; 62: 14–21
   PubMed Web of Science ®Google Scholar
• Monteiro W O, Norshirvani H F, Marks I M, et al. Anorgasmia from clomipramine in obsessive compulsive disorder. a controlled trial. Br J Psychiatry 1987; 151: 107–112
   PubMed Web of Science ®Google Scholar
• Philipp M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction. Int Clin Psychophar-macol 1993; 7: 123–132
   Web of Science ®Google Scholar
• Kennedy S H, Ralevski E, Davis C, Neitzert C. The effects of moclobemide on sexual desire and function in healthy volunteers. Eur Neuropsychopharmacol 1996; 6: 177–181
   PubMed Web of Science ®Google Scholar
• Harrison W M, Rabkin J G, Ehrhardt A A, et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol 1986; 6: 144–149
   PubMed Web of Science ®Google Scholar
• Stark P, Hardison C D. A review of multicenter controlled studies of fluoxetine versus imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985; 46: 53–58
   PubMed Web of Science ®Google Scholar
• Jacobsen F M. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992; 53: 119–122
   PubMed Web of Science ®Google Scholar
• Patterson W M. Fluoxetine-induced sexual dysfunction. J Clin Psychiatry 1993; 54: 71
   PubMed Web of Science ®Google Scholar
• Hsu J H, Shen W W. Male sexual side effects associated with antidepressants: a descriptive study of 32 patients. Int J Psychiatry Med 1995; 25: 191–201
   PubMed Web of Science ®Google Scholar
• Fabre L F, Abuzzahab F S, Amin M, et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatiy 1995; 38: 592–602
   PubMed Web of Science ®Google Scholar
• Medical Economics Data. Paxil (paroxetine hydrochloride). Physician's Desk Reference, 49th edn. Medical Economics Data Production Co., Montvale, NJ 1995; 2390–2396
   Google Scholar
• Ontiveros A, Valdes M, Costilla A. Double-blind comparison of sexual dysfunction on imipramine and paroxetine. Biol Psychiatry 1996; 39: 409
   Google Scholar
• Eison A S, Eison M S, Torrente J R, et al. Nefazodone: preclinical pharmacology of a new antidepressant. Psychopharmacology [Berlin] 1990; 26: 311–315
   Google Scholar
• Marcus R N. Safety and tolerability profile of nefazodone. J Psychopharmacol 1996; 10(suppl.)11–17
   Google Scholar
• Robinson D S, Roberts D L, Smith J M, et al. The safety profile of nefazodone. J Clin Psychiatry 1996; 57(suppl.)31–38
   Google Scholar
• Feiger A, Kiev A, Shrivastava R, et al. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57(suppl.)53–62
   PubMedGoogle Scholar
• Ferguson J M, Shrivastava R, Stahl S M, et al. Effects of double-blind treatment with nefazodone or sertraline on re-emergence of sexual dysfunction in patients with major depressive disorder. American College on Neuropsychopharma-cology, San Juan, Puerto Rico December, 1995
   Google Scholar
• Schweizer E, Feighner J, Mandos L A, et al. Comparison of venlafaxine and imipramine in the acute treatment of major depression in out-patients. J Clin Psychiatry 1994; 55: 104–108
   PubMed Web of Science ®Google Scholar
• Cunningham L A, Borison R L, Carman J S, et al. A comparison of venlafaxine, trazodone and placebo in major depression. J Clin Psychopharmacol 1994; 14: 99–106
   PubMed Web of Science ®Google Scholar
• Margolese H C, Assalian P. Sexual side effects of antidepressants: a review. J Sexual Marital Ther 1996; 22: 209–217
   PubMed Web of Science ®Google Scholar
• de Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol 1995; 10(suppl. 4)19–23
   PubMed Web of Science ®Google Scholar
• Montgomery S A. Safety of mirtazapine: a review. Int Clin Psychopharmacol 1995; 10(suppl. 4)37–45
   PubMed Web of Science ®Google Scholar
• Gardner E A, Johnston J A. Bupropion: an antidepressant without sexual pathophysiological action. J Clin Psychopharmacol 1985; 5: 24–29
   PubMed Web of Science ®Google Scholar
• Walker P W, Cole J O, Gardner E A, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993; 54: 459–465
   PubMed Web of Science ®Google Scholar
• Nathan S G. The epidemiology of DSM-HI psychosexual dysfunctions. J Sex Marital Ther 1986; 12: 267–282
   PubMed Web of Science ®Google Scholar
• Shahar E, Leder J, Herz M J. The use of a self-report questionnaire to assess the frequency of sexual dysfunction in family practice clinics. Family Practice 1991; 8: 206–212
   PubMed Web of Science ®Google Scholar
• Bancroft J. Human Sexuality and its Problems 2nd edit. Churchill Livingstone, Edinburgh 1989
   Google Scholar
• Althof S E, Levine S B, Corty W, et al. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995; 56: 402–407
   PubMed Web of Science ®Google Scholar
• Waldinger M D, Hengeveld M W, Zwinderman A H. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo controlled study. Am J Psychiatry 1994; 151: 1377–1379
   PubMed Web of Science ®Google Scholar
• Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 1995; 15: 341–346
   PubMed Web of Science ®Google Scholar
• Kafka M P. Sertraline therapy pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 1994; 6: 139–145
   Google Scholar
• Bradford J. An open pilot study of sertraline in the treatment of outpatients with pedophilia (poster). 148th Annual Meeting of the American Psychiatric Association, Miami, 1995
   Google Scholar
• Modell J G. Repeated observations of yawning, clitoral engorgement and orgasm associated with fluoxetine treatment. J Clin Psychopharmacol 1994; 9: 63–65
   Google Scholar
• Michael A, Ramana R. Nefazodone-induced spontaneous ejaculation. Br J Psychiatiy 1996; 169: 672–673
   PubMedGoogle Scholar
• Tauscher J, Kasper S. Sexualität und Therapie mit Antidepressiver Medikation. Forum Dr Med 1996; 18: 30–38
   Google Scholar
• Thompson J W, Jr, Ware M R, Blashfield R K. Psychotropic medications and priapism: a comprehensive review. J Clin Psychiatry 1990; 51: 430–433
   PubMed Web of Science ®Google Scholar
• Kilmann P R, Boland J P, Norton S P, et al. Perspectives of sex therapy outcome: a survey of AASECT providers. J Sexual Marital Ther 1986; 12: 116–138
   PubMed Web of Science ®Google Scholar
• Lobitz W C, Baker E L. Group treatment of secondary erectile dysfunction. J Sexual Marital Ther 1979; 8: 127–138
   Google Scholar
• Kaps E C. The role of the support group ‘Us Too’. Cancer 1994; 74: 2188–2189
   PubMed Web of Science ®Google Scholar
• Olivera A A. Sexual dysfunction due to clomipramine and sertraline: non-pharmacological resolution. J Sex Educat Ther 1994; 20: 119–122
   Google Scholar
• Rothschild A J. Selective serotonin re-uptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995; 152: 1514–1516
   PubMed Web of Science ®Google Scholar
• Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry 1991; 52: 163
   PubMed Web of Science ®Google Scholar
• Hollander E R, Mullen L S, Carrasco J L, et al. Symptom relapse in bulimia nervosa and obsessive compulsive disorders after treatment with serotonin antagonists. J Clin Psychiatry 1992; 53: 207–209
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Meerovich, Weizman A. Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an OCD patient. Int Clin Psychopharmacol 1995; 10: 11–114
   Google Scholar
• Kowalski A, Stanley R P, Dennerstein L, et al. The sexual side effects of antidepressant medication: a double-blind comparison of two antidepressants in a non-psychiatric population. Br J Psychiatiy 1985; 147: 413–418
   PubMed Web of Science ®Google Scholar
• Norden M J. Buspirone treatment of sexual dysfunction associated with selective serotonin re-uptake inhibitors. Depression 1995; 2: 109–112
   Google Scholar
• Kirby R S. Impotence: diagnosis and management of male erectile dysfunction. Br Med J 1994; 308: 957–960
   PubMedGoogle Scholar
• Anonymous Alprostadil for erectile impotence. Drugs Therapeutics Bull 1995; 33: 61–62
   Google Scholar
• Gitlin M J. Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches. J Clin Psychiatry 1995; 55: 406–413
   Google Scholar
• Herman J B, Brotman A W, Pollack E, et al. Fluoxtine-induced sexual dysfunction. J Clin Psychiatry 1988; 51: 25–27
   Google Scholar
• Shen W W, Sata L S. Inhibited female orgasm resulting from psychotropic drugs: a clinical review. J Reprod Med 1983; 28: 497–499
   PubMed Web of Science ®Google Scholar
• Shen W W, Sata L S. Inhibited female orgasm resulting from psychotropic drugs: a five-year, update clinical review. J Reprod Med 1990; 35: 11–14
   PubMed Web of Science ®Google Scholar
• Wise T N. A model for the assessment of sexual dysfunction aetiology. J Clin Psychiatry 1992; 10: 11–18
   Google Scholar
• Zajecka J, Fawcett J, Schaff F, et al. The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction. J Clin Psychiatry 1991; 52: 66–68
   PubMed Web of Science ®Google Scholar